Crinetics Pharmaceuticals Statistics
Total Valuation
CRNX has a market cap or net worth of $3.07 billion. The enterprise value is $1.93 billion.
Important Dates
The next estimated earnings date is Thursday, May 8, 2025, after market close.
Earnings Date | May 8, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
CRNX has 93.05 million shares outstanding. The number of shares has increased by 39.11% in one year.
Current Share Class | 93.05M |
Shares Outstanding | 93.05M |
Shares Change (YoY) | +39.11% |
Shares Change (QoQ) | +14.24% |
Owned by Insiders (%) | 1.42% |
Owned by Institutions (%) | 110.16% |
Float | 91.72M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 3,110.28 |
Forward PS | 638.61 |
PB Ratio | 2.44 |
P/TBV Ratio | 2.44 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 1,856.81 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 23.04, with a Debt / Equity ratio of 0.04.
Current Ratio | 23.04 |
Quick Ratio | 22.83 |
Debt / Equity | 0.04 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -32.02% and return on invested capital (ROIC) is -21.53%.
Return on Equity (ROE) | -32.02% |
Return on Assets (ROA) | -20.46% |
Return on Invested Capital (ROIC) | -21.53% |
Return on Capital Employed (ROCE) | -24.65% |
Revenue Per Employee | $2,378 |
Profits Per Employee | -$682,856 |
Employee Count | 437 |
Asset Turnover | 0.00 |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -21.83% in the last 52 weeks. The beta is 0.58, so CRNX's price volatility has been lower than the market average.
Beta (5Y) | 0.58 |
52-Week Price Change | -21.83% |
50-Day Moving Average | 36.05 |
200-Day Moving Average | 48.37 |
Relative Strength Index (RSI) | 46.96 |
Average Volume (20 Days) | 956,794 |
Short Selling Information
The latest short interest is 7.77 million, so 8.35% of the outstanding shares have been sold short.
Short Interest | 7.77M |
Short Previous Month | 8.11M |
Short % of Shares Out | 8.35% |
Short % of Float | 8.47% |
Short Ratio (days to cover) | 7.58 |
Income Statement
In the last 12 months, CRNX had revenue of $1.04 million and -$298.41 million in losses. Loss per share was -$3.69.
Revenue | 1.04M |
Gross Profit | -239.12M |
Operating Income | -338.85M |
Pretax Income | -258.54M |
Net Income | -298.41M |
EBITDA | -336.07M |
EBIT | -338.85M |
Loss Per Share | -$3.69 |
Full Income Statement Balance Sheet
The company has $1.35 billion in cash and $51.72 million in debt, giving a net cash position of $1.30 billion or $14.00 per share.
Cash & Cash Equivalents | 1.35B |
Total Debt | 51.72M |
Net Cash | 1.30B |
Net Cash Per Share | $14.00 |
Equity (Book Value) | 1.32B |
Book Value Per Share | 14.26 |
Working Capital | 1.32B |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$225.97 million and capital expenditures -$3.84 million, giving a free cash flow of -$229.81 million.
Operating Cash Flow | -225.97M |
Capital Expenditures | -3.84M |
Free Cash Flow | -229.81M |
FCF Per Share | -$2.47 |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | -32,613.47% |
Pretax Margin | -28,720.69% |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
CRNX does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -39.11% |
Shareholder Yield | -39.11% |
Earnings Yield | -9.23% |
FCF Yield | -7.11% |
Analyst Forecast
The average price target for CRNX is $73.36, which is 122.03% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $73.36 |
Price Target Difference | 122.03% |
Analyst Consensus | Strong Buy |
Analyst Count | 12 |
Revenue Growth Forecast (5Y) | 310.49% |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
CRNX has an Altman Z-Score of 20.75 and a Piotroski F-Score of 2.
Altman Z-Score | 20.75 |
Piotroski F-Score | 2 |